title: [Hemopurification in the management of ARDS complicating multiple organ failure].
abstract: In the field of critical care medicine, it has been claimed that ARDS often develops as a part of multiple organ failure (MOF). Since multi-modality therapy is necessary in the management of MOF, it is also mandatory even in the management of ARDS. Among the various therapeutic approaches for patients with MOF, hemopurification is one of the most effective therapeutic tools. Various hemopurification methods such as hemodialysis, peritoneal dialysis, hemoadsorption, hemofiltration and plasma exchange have been applied in the management of MOR. However, our recent experiences suggest that continuous hemofiltration (CHF) and/or continuous hemodiafiltration (CHDF) are safest, most easily performed and effective hemopurification in the management of ARDS/MOF. The efficacy of hemopurification in the management of ARDS is summarized as follows. 1) Removal of humoral mediators and causative substances of ARDS following insults such as sepsis and trauma. 2) Treatment of pulmonary interstitial permeability edema which has been claimed to be one of the most important pathological conditions in ARDS. 3) Removal of excess water given as carrier in IVH solution and accumulating in the body. 4) Immunomodulation which has also been considered to be necessary in the treatment or prevention of ARDS.
authors.affiliation: Department of Emergency and Critical Care Medicine, Chiba University School of Medicine, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Hirasawa
authors.forename: T
authors.initials: T
authors.lastname: Sugai
authors.forename: Y
authors.initials: Y
authors.lastname: Ohtake
authors.forename: S
authors.initials: S
authors.lastname: Oda
authors.forename: H
authors.initials: H
authors.lastname: Shiga
authors.forename: K
authors.initials: K
authors.lastname: Matsuda
authors.forename: N
authors.initials: N
authors.lastname: Kitamura
mesh_terms: D006440:Hemofiltration; D006801:Humans; D009102:Multiple Organ Failure / Q000628:therapy*; D010289:Parenteral Nutrition, Total; D006435:Renal Dialysis / Q000379:methods; D012128:Respiratory Distress Syndrome / Q000150:complications / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D014409:Tumor Necrosis Factor-alpha